SCHEMBL4723339

SCHEMBL4723339

CCCOc1[nH][c]nc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.37
TTK P33981 1/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
SQOR Q9Y6N5 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
NLRP3 Q96P20 1/20 0.33
ALOX15 P16050 1/20 0.32
CDC7 O00311 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4723388 0.92 SOAT1 (0.42) SOAT1TTKGAAMAPTTP53
SCHEMBL4724386 0.87 TTK (0.42) TTKMAPTLMNATSHRMEN1
SCHEMBL4721979 0.78 LMNA (0.40) GAAMAPTLMNATSHRMEN1
SCHEMBL4722240 0.77 HTR1B (0.37) MAPTLMNATSHRMEN1KMT2A
SCHEMBL5097262 0.71 TLR8 (0.39) GAALMNAALDH1A1
SCHEMBL4719956 0.70 SOAT1 (0.38) SOAT1GAAMAPTLMNATSHR
SCHEMBL4724605 0.69 MAPT (0.34) TTKGAAMAPTLMNAMEN1
SCHEMBL4724587 0.69 MAPT (0.37) SOAT1GAAMAPTLMNATSHR
SCHEMBL17626333 0.69 SMN1; SMN2 (0.49) TTKMAPTLMNATSHRMEN1
SCHEMBL1902062 0.69 ALOX15 (0.41) TTKGAAMAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 SOAT1 3558/4885TTK 3112/4885GAA 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.